Walgreens Boots Alliance, Inc. Website

Walgreens Boots Alliance, Inc.

NasdaqGS-WBA

Basic

  • Market Cap

    $13.83B

  • EV

    $49.66B

  • Shares Out

    862.71M

  • Revenue

    $144.6B

  • Employees

    268,500

Margins

  • Gross

    18.59%

  • EBITDA

    2.57%

  • Operating

    1.14%

  • Pre-Tax

    -9.82%

  • Net

    -4.18%

  • FCF

    -1.22%

Returns (5Yr Avg)

  • ROA

    1.65%

  • ROTA

    8.3%

  • ROE

    5%

  • ROCE

    5.88%

  • ROIC

    3.8%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    $22.77

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    $676M

  • Net Debt

    $33.95B

  • Debt/Equity

    2.25

  • EBIT/Interest

    2.79

Growth (CAGR)

  • Rev 3Yr

    4.99%

  • Rev 5Yr

    1.22%

  • Rev 10Yr

    6.9%

  • Dil EPS 3Yr

    113.64%

  • Dil EPS 5Yr

    5.61%

  • Dil EPS 10Yr

    9.52%

  • Rev Fwd 2Yr

    4.13%

  • EBITDA Fwd 2Yr

    1.88%

  • EPS Fwd 2Yr

    -10.33%

  • EPS LT Growth Est

    -4.38%

Dividends

  • Yield

  • Payout

    -24.16%

  • DPS

    $1.69

  • DPS Growth 3Yr

    -3.14%

  • DPS Growth 5Yr

    -0.35%

  • DPS Growth 10Yr

    3.31%

  • DPS Growth Fwd 2Yr

    1.51%

Select a metric from the list below to chart it

Aug '14

Aug '15

Aug '16

Aug '17

Aug '18

Aug '19

Aug '20

Aug '21

Aug '22

Aug '23

LTM

Aug '24 (E)

Aug '25 (E)

Aug '26 (E)

Total Revenues

120,074

121,982

132,509

132,703

139,081

144,597

Total Revenues % Chg.

-8.7%

1.6%

8.6%

0.1%

4.8%

8.5%

Cost of Goods Sold, Total

91,915

95,905

104,442

104,437

112,009

117,721

Gross Profit

28,159

26,077

28,067

28,266

27,072

26,876

Selling General & Admin Expenses, Total

23,183

22,836

23,798

24,627

24,860

25,226

Other Operating Expenses, Total

23,183

22,836

23,798

24,627

24,860

25,226

Operating Income

4,976

3,241

4,269

3,639

2,212

1,650

Interest Expense, Total

-676

-584

-916

-420

-606

-591

Interest And Investment Income

26

425

24

26

26

Net Interest Expenses

-650

-584

-491

-396

-580

-565

Income (Loss) On Equity Invest.

172

372

-512

468

285

279

Currency Exchange Gains (Loss)

121

11

-8

523

-273

-148

Other Non Operating Income (Expenses)

38

-37

83

-602

275

-732

EBT, Excl. Unusual Items

4,657

3,003

3,341

3,632

1,919

484

Restructuring Charges

-352

-125

-417

-763

-1,181

-1,686

Merger & Related Restructuring Charges

-315

-54

-223

-323

-548

Impairment of Goodwill

-1,700

-12,369

Gain (Loss) On Sale Of Investments

-70

290

2,945

1,964

1,303

Gain (Loss) On Sale Of Assets

-270

Asset Writedown

-80

-316

-49

-783

-299

-299

Legal Settlements

-31

-75

-768

-7,466

-809

Other Unusual Items

173

-414

-4

EBT, Incl. Unusual Items

4,367

477

2,622

4,036

-5,386

-14,194

Income Tax Expense

577

339

667

-30

-1,858

-1,337

Earnings From Continuing Operations

3,790

138

1,955

4,066

-3,528

-12,857

Earnings Of Discontinued Operations

166

277

548

Minority Interest

26

41

39

271

448

6,820

Net Income

3,982

456

2,542

4,337

-3,080

-6,037

Net Income to Common Incl Extra Items

3,982

456

2,542

4,337

-3,080

-6,037

Net Income to Common Excl. Extra Items

3,816

179

1,994

4,337

-3,080

-6,037

Total Shares Outstanding

895.4

865.6

865.4

864.6

863.7

862.7

Weighted Avg. Shares Outstanding

921.5

879.4

864.8

864.4

863.2

863.1

Weighted Avg. Shares Outstanding Dil

923.5

880.3

866.4

865.9

863.2

863.1

EPS

4.3

0.5

2.9

5

-3.6

-7

EPS Diluted

4.3

0.5

2.9

5

-3.6

-7

EBITDA

6,754

4,868

5,958

5,322

4,098

3,711

Effective Tax Rate

13.2%

71.1%

25.4%

-0.7%

34.5%

9.4%